CLOSE X
GO

Bajaj Finserv Healthcare Fund-Reg(G)

very highequitypharma & health care
9.19 -0.18(-1.92%) NAV as on 13 Mar 2026
-2.34 % 1 M
5.64 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.39

As on 28 Feb, 2026
age-icon Age :

1 yrs 2 m

Since 27 12 ,2024
exit_load Exit Load :

1%

aum AUM :

314.74 Crs

lock_in Lock-in :

1% on or before 3M, Nil after 3M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.62

Min_Investment Min. Investment :

SIP 1000 & Lumpsum 500

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Nimesh Chandan,Sorbh Gupta,Siddharth Chaudhary

LATEST ASSET & PORTFOLIO ALLOCATION

as on Feb 28 ,2026
Others 2.47 %
Equity 97.53 %

TOP HOLDINGS

Divi's Laboratories Ltd.9.21 %
Sun Pharmaceutical Industries...8.40 %
Apollo Hospitals Enterprise Ltd.6.80 %
Piramal Pharma Ltd.6.21 %
Aurobindo Pharma Ltd.5.93 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs61.07
Hospital & Healthcare Services19.52
Household & Personal Products4.04
Miscellaneous3.70
Consumer Food2.01
See All Sectors

5-YEARS HISTORY

Financial Year2024-20252025-2026
NAV in Rs (as on 12-Mar-2026)9.089.37
Net Assets(Rs Crores) (as on 12-Mar-2026) 307.40 314.74
Scheme Returns(%)(Absolute)-9.214.53
B'mark Returns(%)(Absolute)NANA
Category Rank95/10253/118

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Bajaj Finserv Healthcare Fund-Reg(G)Very HighEquity9.19-0.18(-1.92%)NAV As on 13 Mar, 202627-Dec-2024Inception Date314.74AUM In Cr.5.64%1YNA%3YNA%5Y-6.74%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.61-0.62(-1.62%)NAV As on 13 Mar, 202613-Jul-2018Inception Date6,801.16AUM In Cr.8.17%1Y27.53%3Y16.59%5Y18.85%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity31.24-0.16(-0.51%)NAV As on 13 Mar, 202610-Jul-2019Inception Date854.04AUM In Cr.11.41%1Y24.45%3Y14.38%5Y18.60%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors